Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Juliet Tammenoms Bakker
AddedMar 31, 2024
UpdatedMay 31, 2026
Juliet Tammenoms Bakker

Juliet Tammenoms Bakker

Co-Founder, Longitude Capital

CrunchbaseLinkedIn

Juliet Tammenoms Bakker's Career

Longitude Capital
Longitude Capital

Menlo Park, CA, US

Co-Founder
RxSight
RxSight

Aliso Viejo, CA, US

Board Member· Board
Endogenex
Endogenex

Plymouth, MN, US

Board Member· Board
Encore Dermatology
Encore Dermatology

Malvern, PA, US

Board Member· Board
Nalu Medical
Nalu Medical

Carlsbad, CA, US

Board Member· Board
Ceribell
Ceribell

Mountain View, CA, US

Board Member· Board
Alphaeon
Alphaeon

Irvine, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Juliet Tammenoms Bakker's Career

Longitude Capital
Longitude Capital
Investment FirmInvestment Firm452006Menlo Park, CA, US
Co-Founder

Leadership at Longitude Capital

Andrew CleelandAndrew CleelandBoard Member
David HirschDavid HirschCo-Founder
Lisa SuennenLisa SuennenBoard Member
Patrick EnrightPatrick EnrightCo-Founder
Andrew ElbardissiAndrew ElbardissiBoard Member
Marc-Henri GallettiMarc-Henri GallettiCo-Founder

Similar to Longitude Capital

Longwood FundLongwood FundBoston, MA, USest. 2010Longwood FundBoston, MA, US · est. 2010

Longwood Fund Management: A US-based venture capital firm specializing in healthcare and biotech investments.

Investment Firm20
Longevity Vision FundLongevity Vision FundNew York City, NY, USest. 2019Longevity Vision FundNew York City, NY, US · est. 2019

LVF: A venture capital fund investing in disruptive healthcare technologies for longer, healthier lives.

Investment Firm15
Longley CapitalLongley CapitalSan Diego, CA, USest. 2019Longley CapitalSan Diego, CA, US · est. 2019

Longley Capital: A tech-focused investment firm, nurturing visionary ideas to boost enterprise value.

Investment Firm2
The Longevity FundThe Longevity FundSan Francisco, CA, USest. 2011The Longevity FundSan Francisco, CA, US · est. 2011

Longevity Fund: Investing in human longevity through innovative investment solutions.

Investment Firm2
RxSight
RxSight

Aliso Viejo, CA, US

Board Member· Board
Endogenex
Endogenex

Plymouth, MN, US

Board Member· Board
Encore Dermatology
Encore Dermatology

Malvern, PA, US

Board Member· Board
Nalu Medical
Nalu Medical

Carlsbad, CA, US

Board Member· Board
Ceribell
Ceribell

Mountain View, CA, US

Board Member· Board
Alphaeon
Alphaeon
Series B$277.1M1752013Irvine, CA, US
Board Member· Board

Leadership at Alphaeon

Thomas ErvesunThomas ErvesunCEO
Robert HaymanRobert HaymanBoard Member
Robert Edward GrantRobert Edward GrantBoard Member
Hans S KeirsteadHans S KeirsteadBoard Member
Simone BlankSimone BlankBoard Member

Juliet Tammenoms Bakker's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Juliet Tammenoms Bakker

Ann HanhamAnn HanhamBoard Member · HTG Molecular DiagnosticsGregory OstrowGregory OstrowFounder · SydnexisGregg HonigblumGregg HonigblumFounder · Creation CapitalBarry MichaelsBarry MichaelsBoard Member · ZynexJulie CullivanJulie CullivanBoard Member · Axon EnterpriseElizabeth CrainElizabeth CrainBoard Member · Nokia